You will need to create artificial RNA with the right code to generate protein spikes. These genetic materials are to be delivered into the human body to trigger immunity.
You can check the institutions that have developed RNA Vaccine.
Although this method is yet to successfully produce a vaccine, by the end of June 4, 2020, companies have moved on to phase II clinical trials.
You can choose to develop RNA Vaccine or consider a different strategy.
A vaccine candidate from a company called Moderna has entered phase II clinical trial. You can partner with Moderna or develop your own vaccine.
Whoops, we haven’t established partnership with Moderna yet.
You can begin cooperation Remember though, time is not on your side.
Indonesia has virtually zero experience in this vaccine development technology. You will have to start from the very beginning. Not the best move.
Go check alternative strategies.
RNA vaccine is very new and will be accompanied by a patent. You may start working together, but please carefully consider the potential benefits and cost. If the vaccine turns out to be effective, Moderna is likely to grant production rights to an Indonesian company through a licensing scheme, which, by the way, is not cheap. Go check alternative strategies.
